Moderna stock rockets more than 90% after cancer vaccine succeeds in late-stage trial CTech 3h CTech 3h Moderna mRNA FDA All sources
Moderna's cancer vaccine win is Merck's story too Benzinga 17m Benzinga 17m Moderna mRNA Nasdaq Article paywall All sources
Moderna vaccine appeal poised to set patent liability benchmark Bloomberg Law 6d Bloomberg Law 6d Moderna Coronavirus Vaccine Health All sources
5 things to know about Moderna’s new mRNA flu vaccine Pittsburgh Tribune-Review 21:18 Fri, 07 Aug Pittsburgh Tribune-Review 21:18 Fri, 07 Aug Moderna mRNA Flu All sources
Q&A: First approved seasonal flu vaccine using mRNA technology is ready for the coming season Digital Journal 8d Digital Journal 8d mRNA FDA Flu Pandemics
Cancer vaccine shows promise in preventing recurrance of melanoma, Merck and Moderna say Just The News 16:21